New study rates vaccine in malaria treatment

The R21 malaria vaccine has been prequalified by the World Health Organisation, offering a cost-effective solution for combating malaria in Africa, according to a study published by 1Day Africa, a global non-profit. The report highlighted that the vaccine’s cost-effectiveness rivals that of insecticide-treated bed nets, long considered a gold standard in malaria prevention. “The R21

Read More